Cleared Traditional

K192326 - HardyDisk AST Lefamulin 20µg (LMU20) (FDA 510(k) Clearance)

Sep 2019
Decision
23d
Days
Class 2
Risk

K192326 is an FDA 510(k) clearance for the HardyDisk AST Lefamulin 20µg (LMU20). This device is classified as a Susceptibility Test Discs, Antimicrobial (Class II - Special Controls, product code JTN).

Submitted by Hardy Diagnostics (Santa Maria, US). The FDA issued a Cleared decision on September 19, 2019, 23 days after receiving the submission on August 27, 2019.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1620.

Submission Details

510(k) Number K192326 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 2019
Decision Date September 19, 2019
Days to Decision 23 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code JTN — Susceptibility Test Discs, Antimicrobial
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1620

Similar Devices — JTN Susceptibility Test Discs, Antimicrobial

All 8
HardyDisk AST Cefiderocol 30µg (FDC30)
K253105 · Hardy Diagnostics · Nov 2025
HardyDisk AST Gepotidacin 10µg (GEP10)
K250956 · Hardy Diagnostics · Jun 2025
HardyDisk Aztreonam/Avibactam 30/20µg (AZA50)
K250454 · Hardy Diagnostics · May 2025
HardyDisk AST Cefiderocol 30µg (FDC30)
K241060 · Hardy Diagnostics · Jul 2024
HardyDisk AST Sulbactam/Durlobactam 10/10µg (SUD20)
K231568 · Hardy Diagnostics · Jul 2023
BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)
K230651 · Becton, Dickinson and Company · Jun 2023